BIROn - Birkbeck Institutional Research Online

    Rationally designed novel Phenyloxazoline Synthase Inhibitors: chemical synthesis and biological evaluation to accelerate the discovery of new antimycobacterial antibiotics

    Shyam, M. and Bhattacharje, G. and Daniel, C. and Kumar, A. and Yadav, P. and Mukherjee, P. and Singh, S. and Das, A.K. and Narender, T. and Singh, A. and Jayaprakash, V. and Bhakta, Sanjib (2023) Rationally designed novel Phenyloxazoline Synthase Inhibitors: chemical synthesis and biological evaluation to accelerate the discovery of new antimycobacterial antibiotics. Molecules 28 (24), p. 8115. ISSN 1420-3049.

    [img]
    Preview
    Text
    molecules-28-08115-v3.pdf - Published Version of Record
    Available under License Creative Commons Attribution.

    Download (4MB) | Preview

    Abstract

    The uncontrolled spread of drug-resistant tuberculosis (DR-TB) clinical cases necessitates the urgent discovery of newer chemotypes with novel mechanisms of action. Here, we report the chemical synthesis of rationally designed novel transition-state analogues (TSAs) by targeting the cyclization (Cy) domain of phenyloxazoline synthase (MbtB), a key enzyme of the conditionally essential siderophore biosynthesis pathway. Following bio-assay-guided evaluation of TSA analogues preferentially in iron-deprived and iron-rich media to understand target preferentiality against a panel of pathogenic and non-pathogenic mycobacteria strains, we identified a hit, i.e., TSA-5. Molecular docking, dynamics, and MMPBSA calculations enabled us to comprehend TSA-5’s stable binding at the active site pocket of MbtB_Cy and the results imply that the MbtB_Cy binding pocket has a strong affinity for electron-withdrawing functional groups and contributes to stable polar interactions between enzyme and ligand. Furthermore, enhanced intracellular killing efficacy (8 μg/mL) of TSA-5 against Mycobacterium aurum in infected macrophages is noted in comparison to moderate in vitro antimycobacterial efficacy (64 μg/mL) against M. aurum. TSA-5 also demonstrates whole-cell efflux pump inhibitory activity against Mycobacterium smegmatis. Identification of TSA-5 by focusing on the modular MbtB_Cy domain paves the way for accelerating novel anti-TB antibiotic discoveries.

    Metadata

    Item Type: Article
    Keyword(s) / Subject(s): mycobactin metabolism, phenyloxazoline synthase, cyclization domain, transition-state analogues, MD simulations, MMPBSA studies, intracellular killing, efflux pump
    School: Birkbeck Faculties and Schools > Faculty of Science > School of Natural Sciences
    Depositing User: Chris Daniel
    Date Deposited: 22 Apr 2024 13:16
    Last Modified: 23 Apr 2024 07:15
    URI: https://eprints.bbk.ac.uk/id/eprint/53415

    Statistics

    Activity Overview
    6 month trend
    480Downloads
    6 month trend
    79Hits

    Additional statistics are available via IRStats2.

    Archive Staff Only (login required)

    Edit/View Item
    Edit/View Item